NMPA-Approved Drug Library | N

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

NMPA-Approved Drug Library

MCE 国际站：NMPA-Approved Drug Library

From target identification to clinical research, traditional drug discovery and development is a time-consuming and costly process, which also bears high risk. Compared with traditional drug discovery, drug repositioning or repurposing, also known as old drugs for new uses can greatly shorten the development cycle and reduce development cost, which has become a new trend of drug development. After undergoing clinical trials, approved drugs have identified bioactivities, good pharmacokinetic characteristics and safety, which can greatly improve the success rate of drug discovery. A number of successes have been achieved, such as metformin for type 2 diabetes and thalidomide for leprosy and multiple myeloma, etc.MCE provides a unique collection of 1357 China NMPA (National Medical Products Administration) approved compounds, which have undergone extensive preclinical and clinical studies and have well-characterized bioactivities, safety and bioavailability properties. MCE NMPA-Approved Drug Library is a good tool for drug repurposing which could dramatically accelerate drug development.

Description & Advantages:

•   A unique collection of 1357 approved compounds for high throughput screening (HTS) and high content screening (HCS).

•   Used in the research of oncology, cardiology, anti-inflammatory, immunology, dermatology, endocrinology, neurology, and more.

•   A useful tool for researching new targets of marketed old drugs.

•   All compounds have been approved by the NMPA.

•   Structurally diverse, bioactive, and cell permeable.

•   More detailed compound information with structure, IC₅₀, and brief introduction.

•   NMR and HPLC validated ensure high purity.

•   All compounds are in stock and continuously updated.